These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 15956162)
1. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism. Hauser MA; Li YJ; Xu H; Noureddine MA; Shao YS; Gullans SR; Scherzer CR; Jensen RV; McLaurin AC; Gibson JR; Scott BL; Jewett RM; Stenger JE; Schmechel DE; Hulette CM; Vance JM Arch Neurol; 2005 Jun; 62(6):917-21. PubMed ID: 15956162 [TBL] [Abstract][Full Text] [Related]
2. A case of frontotemporal dementia and parkinsonism of early onset with progressive supranuclear palsy-like features. Miyamoto K; Ikemoto A; Akiguchi I; Kohno R; Imura T; Fujita Y Clin Neuropathol; 2001; 20(1):8-12. PubMed ID: 11220696 [TBL] [Abstract][Full Text] [Related]
3. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata. Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169 [TBL] [Abstract][Full Text] [Related]
4. Genomic convergence to identify candidate genes for Parkinson disease: SAGE analysis of the substantia nigra. Noureddine MA; Li YJ; van der Walt JM; Walters R; Jewett RM; Xu H; Wang T; Walter JW; Scott BL; Hulette C; Schmechel D; Stenger JE; Dietrich F; Vance JM; Hauser MA Mov Disord; 2005 Oct; 20(10):1299-309. PubMed ID: 15966006 [TBL] [Abstract][Full Text] [Related]
5. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Bukhatwa S; Zeng BY; Rose S; Jenner P Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003 [TBL] [Abstract][Full Text] [Related]
6. Calbindin-D28k in the basal ganglia of patients with parkinsonism. Ito H; Goto S; Sakamoto S; Hirano A Ann Neurol; 1992 Oct; 32(4):543-50. PubMed ID: 1456738 [TBL] [Abstract][Full Text] [Related]
7. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Jellinger KA Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518 [TBL] [Abstract][Full Text] [Related]
8. [A 65-year-old man with Parkinsonism, gaze palsy, and dementia]. Mizuno Y; Yokochi F; Ohta S; Mori H; Takubo H No To Shinkei; 1996 Apr; 48(4):381-93. PubMed ID: 8679336 [TBL] [Abstract][Full Text] [Related]
9. A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene. Soliveri P; Rossi G; Monza D; Tagliavini F; Piacentini S; Albanese A; Bugiani O; Girotti F Arch Neurol; 2003 Oct; 60(10):1454-6. PubMed ID: 14568818 [TBL] [Abstract][Full Text] [Related]
10. Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia. Hirano S; Shinotoh H; Shimada H; Aotsuka A; Tanaka N; Ota T; Sato K; Ito H; Kuwabara S; Fukushi K; Irie T; Suhara T Brain; 2010 Jul; 133(Pt 7):2058-68. PubMed ID: 20558417 [TBL] [Abstract][Full Text] [Related]
11. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592 [TBL] [Abstract][Full Text] [Related]
14. Altered gene expression profiles reveal similarities and differences between Parkinson disease and model systems. Miller RM; Federoff HJ Neuroscientist; 2005 Dec; 11(6):539-49. PubMed ID: 16282595 [TBL] [Abstract][Full Text] [Related]
15. Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Rinne JO; Rummukainen J; Paljärvi L; Rinne UK Ann Neurol; 1989 Jul; 26(1):47-50. PubMed ID: 2549846 [TBL] [Abstract][Full Text] [Related]
16. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains. Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707 [TBL] [Abstract][Full Text] [Related]
17. Subcortical neurofibrillary tangles and argyrophilic grains in a case of familial frontotemporal dementia with parkinsonism. Kobayashi K; Sudo S; Matsubara R; Nakano H; Koshino Y Parkinsonism Relat Disord; 2008 Aug; 14(6):513-6. PubMed ID: 18346925 [TBL] [Abstract][Full Text] [Related]
18. Topographic investigation of brain atrophy in parkinsonism-dementia complex of Guam: a comparison with Alzheimer's disease and progressive supranuclear palsy. Oyanagi K; Makifuchi T; Ohtoh T; Ikuta F; Chen KM; Chase TN; Gajdusek DC Neurodegeneration; 1994 Dec; 3(4):301-4. PubMed ID: 7842300 [TBL] [Abstract][Full Text] [Related]
19. Parkinsonism and extraocular motor abnormalities with unusual neuropathological findings. Calabrese VP; Hadfield MG Mov Disord; 1991; 6(3):257-60. PubMed ID: 1922131 [TBL] [Abstract][Full Text] [Related]
20. Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease. Miller RM; Kiser GL; Kaysser-Kranich TM; Lockner RJ; Palaniappan C; Federoff HJ Neurobiol Dis; 2006 Feb; 21(2):305-13. PubMed ID: 16143538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]